Cannabis and Hemp Industry Investment News

if granted, the company could process cannabis products at its current facility in Ontario with minimal additional capital expenditures Health Canada ...

The letter of intent (LOI) will grant NewCanna the right to sell and distribute certain of Canntab's proprietary products Canntab has struck a deal wi...

What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics () CFO Richard Goldstein joined Steve Darling from Proactive Investors o...

FSD has received the first delivery of manufacturing equipment at its Cobourg plant in Ontario Canntab is developing pot pills Cannabis pill focused d...

Shares in Canntab surged this week after the company unveiled positive test results on its oral extended release formulation The firm's shares reached...

Canntab plans to provide pot pills to patients and doctors in Canada Pot pill developer () noted the highs reached by its share price Tuesday followin...

What are you searching for? viewCanntab Therapeutics Ltd . () CFO Richard Goldstein joined Proactive Investors Vancouver on Skype, with big news about...

FSD will provide Canntab with up to 10,000 sq ft at its facility, which lies one hour east of Toronto in Cobourg, Ontario Canntab has developed in-hou...

Under the LOI, FSD Pharma will help Canntab to obtain a licence to process and sell cannabis products Cannabis-pill firm () is launching a new communi...

What are you searching for? viewCanntab Therapeutics Ltd () CEO Jeff Renwick and CFO Richard Goldstein tell Proactive Investor's Christine Corrado the...

Serial entrepreneur Lorne Gertner has become a strategic consultant to the company, it said Gertner reckons the solution to delivering cannabis is via...

Canntab will build, at its own expense, its own manufacturing facility to produce cannabis oral dose delivery platforms Under the plan, Canntab will h...

Each capsule contains 50 milligrams (mg) of purified hemp seed oil extracted from cannabis sativa and suspended in coconut oil. Hemp oil is supposed t...

Ontario-based Canntab is developing advanced pharmaceutical-grade formulations of cannabinoids Canntab is developing advanced pharmaceutical-grade for...

The tablets can treat arthritis, post-traumatic stress disorder and other ailments The cannabis market is full of potential and creativity, with compa...

The pot pill maker filed applications related to the company’s technologies in oral dosing Canntab is the first company to offer medical marijuana in ...

Canntab is an Ontario-based cannabis oral dosage formulation company () announced it has appointed pharmaceutical executive Bob Woloschuk to its advis...

Canntab says it will begin making the first pivotal batch of the product this week The pair struck a collaboration and licensing deal in October last ...

The company recently made three additional US patent applications and one international patent application The company is developing pharmaceutical pr...

The company's Australian JV partner recently entered into a binding MoU with Burleigh Heads Cannabis, which holds an import licence issued by the Aust...